Skip to content
FrontierPicks

Research through the 18 September 2026 close

Search

Themes · 21 current · 19 dormant · 942 dossiers

Names that move as a basket.

Themes are treated as primary, not afterthoughts. The model reads cluster co-movement alongside standalone setup — cluster confirmation can lift a single-name conviction; cluster failure can downgrade it. See the glossary for the full definition.

Discovery views

Themes in motion → consumer retail stocks · 4 crypto exchange and stablecoin stocks · 7 freight and logistics stocks · 5 medtech stocks · 7 analog semiconductor stocks · 4 AI compute stocks · 9

Theme weight · dossiers per theme

Strongest clusters · shared dossiers

Jump to a theme

Precision biotech & therapeutics 124 AI datacenter infrastructure 123 AI enterprise software 92 M&A & special situations 78 Cyclical industrials 70 Consumer discretionary rotation 69 Binary-catalyst biotech 68 Medtech & diagnostics 63 Oncology & immunology 63 Managed care & health services 57 Oil, energy & geopolitical 44 Freight & logistics 43 AI chips & memory 40 Critical materials & rare earths 36 Semi foundry & equipment 35 Industrial power & grid 33 Cybersecurity 31 Defense & aerospace 28 Fintech & consumer credit 27 Crypto exchanges & financials 26 Housing, homebuilders & proptech 23 Rare disease & gene therapy 23 Networking & optical 19 Travel & leisure 18 GPU cloud & neoclouds 17 Analog semiconductors 17 Space economy 17 Emerging markets 15 Physical AI & robotics 14 Squeeze & momentum setups 13 Biofuels & low-carbon fuels 11 EV & autonomous mobility 11 Nuclear & uranium 10 Solar & clean energy 7 Bitcoin miners 6 Mega-cap AI platforms 6 Prediction markets & betting 6 Quantum computing 6 Small-cap value rotation 5 Cannabis reclassification 3

Precision biotech & therapeutics

124 dossiers

Worked today · saturated.

APGE Apogee Therapeutics, Inc. fresh SUPREME Apogee Therapeutics’ $135.11-per-share cash-acquisition thesis resolved with AbbVie’s completion on 2026-09-03. The 2026-09-14 Form 15 advances administrative closure, leaving no unresolved APGE acquisition catalyst. Earnings inflection · M&A & special situations · Precision biotech & therapeutics catalyst · ATAI AtaiBeckley Inc. fresh SUPREME AtaiBeckley's Lilly acquisition thesis resolved with completion on 2026-09-11, ending the pending-merger case. Remaining contingent payments depend on disclosed clinical and regulatory milestones; Nasdaq suspended ATAI effective 2026-09-14. Earnings inflection · M&A & special situations · Precision biotech & therapeutics analysed · RVMD Revolution Medicines, Inc. fresh HIGH Regulatory-clock narrative re-accelerating: the rolling NDA under the FDA National Priority Voucher is "nearing completion" (2026-07-07) and the EMA opened a phased CHMP review the same day, while the Street ceiling walked from ~$186 to… Compounder · Precision biotech & therapeutics · Oncology & immunology catalyst · ABCL AbCellera Biologics Inc. fresh MEDIUM AbCellera's monthly hot-flash antibody thesis requires the 2026-10-01 presentation to preserve the Phase 2 efficacy case and a subsequent weekly close above $12.73; a weekly close below $9.75 invalidates it. Earnings inflection · Precision biotech & therapeutics catalyst · ABSI Absci Corporation fresh MEDIUM Absci Corporation’s valuation rests on ABS-201 delivering human hair-growth efficacy in the guided second half of 2026. Separation from placebo would validate the case; a weekly close below $7.50, absent efficacy or a missed readout window… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics analysed · AQST Aquestive Therapeutics, Inc. MEDIUM Aquestive Therapeutics' recovery thesis rests on an Anaphylm resubmission by 2026-09-30, following its August usability results. A filing announcement before a weekly close below $4.47 would satisfy the near-term case; missing the deadline… Earnings inflection · Precision biotech & therapeutics catalyst · CMPS COMPASS Pathways Plc MEDIUM Compass Pathways’ September 9 COMP360 durability update renews the regulatory revaluation case ahead of its company-guided Q4 2026 submission. A weekly close above the September 11 series’ $15.17 52-week high would confirm the price… Earnings inflection · Precision biotech & therapeutics catalyst · CRDL Cardiol Therapeutics Inc. Class A MEDIUM Cardiol Therapeutics’ enrollment-led re-rating requires MAVERIC completion by 2026-09-30 and a weekly close above $2.29 before a weekly close below $1.75. The 2026-09-10 preliminary shelf introduces financing capacity, but the announcement… Earnings inflection · Precision biotech & therapeutics catalyst · CYRX CryoPort, Inc. MEDIUM Q2 (2026-08-06) split the read: revenue $49.0M beat $48.21M and FY26 guide affirmed at $192–196M with adjusted EBITDA crossing to +$0.4M, but commercial CGT growth halved to +9% YoY from +26%. The narrative leg is now the profitability… Cyclical recovery · Rare disease & gene therapy · Precision biotech & therapeutics catalyst ·

All 124 Precision biotech & therapeutics dossiers →

AI datacenter infrastructure

123 dossiers

Worked today · saturated.

HPE Hewlett Packard Enterprise Company fresh HIGH Hewlett Packard Enterprise's AI and networking earnings transition supports a repricing thesis that requires intact growth guidance and the first weekly close above $54.44 after the 2026-09-30 Investor Day. A weekly close below $50… Special situation · AI datacenter infrastructure catalyst · NTAP NetApp, Inc. fresh MEDIUM NetApp's AI storage recovery requires delivery of September guidance before a weekly close below $164 breaks the thesis. Fiscal-Q2 revenue of at least $2.025 billion and non-GAAP gross margin of at least 67.0%, with the annual revenue… Special situation · AI datacenter infrastructure catalyst · XMTR Xometry, Inc. fresh MEDIUM Xometry's AI manufacturing thesis requires enterprise adoption to deliver its August 4 guidance before a weekly close below $85. Third-quarter revenue of at least $234 million and adjusted EBITDA of at least $16 million, with the 33–34%… Theme leader · AI datacenter infrastructure analysed · DELL Dell Technologies Inc. fresh LOW Dell Technologies’ AI-server thesis requires roughly $19 billion of next-quarter revenue and infrastructure operating margin of at least 15.0%. The next quarterly results settle that case; September 21, 2026 index inclusion does not… Cyclical recovery · AI datacenter infrastructure catalyst · SNX TD SYNNEX Corporation fresh LOW TD SYNNEX's Hyve expansion supports an AI hardware earnings story, tested by revenue above $19.0 billion and adjusted diluted EPS above $4.75 on 2026-09-24. A weekly close below $255 invalidates the September price structure; stronger… Theme leader · AI datacenter infrastructure catalyst · CLSK CleanSpark, Inc. fresh HIGH Spring's binary resolved bullish: CleanSpark signed a $6.6B, 20-year Georgia data-center lease (2026-07-14) with an unnamed "global technology company," converting the BTC-miner-to-AI-infrastructure pivot from speculation into contracted… Special situation · Bitcoin miners · AI datacenter infrastructure catalyst · AGM Federal Agricultural Mortgage Corporation fresh MEDIUM Federal Agricultural Mortgage Corporation's infrastructure lending supports an earnings-led re-rating. The next quarterly report tests whether spread income grows with volume; a weekly close above $240.02 fulfills the price case, while a… Theme leader · Biofuels & low-carbon fuels · AI datacenter infrastructure catalyst · CLDT Chatham Lodging Trust fresh MEDIUM Chatham Lodging Trust’s raised earnings outlook depends on sustained Silicon Valley hotel demand. The case resolves if third-quarter results preserve the August 4 guidance and regional outperformance before a weekly close below $12.00. Theme leader · AI datacenter infrastructure catalyst · CRWV CoreWeave, Inc. fresh MEDIUM Post-print repricing is holding but fading: the 2026-08-12 gap to $107.73 is unfilled after closes of $106.29 and $105.26, RSI 71.1. Q2 printed $128M adjusted operating income against a $30–90M guide, and the $2.6B facility closed… Compounder · GPU cloud & neoclouds · AI datacenter infrastructure catalyst ·

All 123 AI datacenter infrastructure dossiers →

AI enterprise software

92 dossiers

Worked today · saturated.

APPN Appian Corporation fresh MEDIUM Appian’s AI orchestration re-rating needs Q3 revenue of at least $214 million and cloud subscriptions of at least $133 million to confirm management’s August guidance. A weekly close below $34 or a miss against either revenue floor… Theme leader · AI enterprise software analysed · CRM Salesforce, Inc. fresh MEDIUM De-rated Dow software incumbent on two dated legs: the $1.6B VA agentic ELA (2026-07-24) and Reuters' 2026-08-13 report of Silver Lake–Workday take-private talks, which put a private-market floor under mega-cap SaaS. Six target revisions… Special situation · AI enterprise software analysed · CRWD CrowdStrike Holdings, Inc. fresh MEDIUM Fal.Con (2026-08-31 to 09-03) delivered real product — Falcon Guardian, Falcon IQ, GPT-5.6 Cyber in Falcon, Anthropic marketplace distribution — and nine broker actions through 2026-09-04 including Truist $300, yet CRWD closed $213.10 on… Compounder · Cybersecurity · AI enterprise software analysed · FROG JFrog Ltd. fresh MEDIUM Software-supply-chain-security plus AI-agent "trust layer" narrative keeps re-rating: the analyst cluster now leads price above $100 (UBS Buy $110 Jul 2, Truist Buy $105 Jul 9), confirming the continuation tell flagged in June.… Theme leader · Cybersecurity · AI enterprise software analysed · GTLB GitLab Inc. fresh MEDIUM GitLab's consumption-pricing story needs coding-agent usage to lift revenue above its September guidance. Fiscal Q3 revenue above $283 million and a paid-consumption run-rate above September's $40 million reference would confirm the case… Theme leader · AI enterprise software catalyst · MGNI Magnite, Inc. fresh MEDIUM Magnite's connected-TV growth now has an AI advertising catalyst; a weekly close above $25.92 and reaffirmed 2026 guidance at the next quarterly report would validate the next leg. A weekly close below $21 invalidates the price structure. Theme leader · AI enterprise software analysed · NAVN Navan, Inc. fresh MEDIUM Q2 FY2027 prints 2026-09-09 with the first positive non-GAAP operating-income guide ($13.5–14.5M) on the line. Four target raises in 21 days — BofA $26→$34 on 09-02, Morgan Stanley $33 on 09-04 — landed while the shares fell from the… Earnings inflection · AI enterprise software · Travel & leisure analysed · NET Cloudflare, Inc. MEDIUM Cloudflare’s AI security and agent-infrastructure story supports a recovery toward its recorded $330.83 high. The case plays out on a weekly close above that level by the listed 2026-10-29 results date and fails on a weekly close below… Cyclical recovery · AI enterprise software · AI datacenter infrastructure catalyst · NIQ NIQ Global Intelligence plc MEDIUM NIQ Global Intelligence’s deleveraging re-rating needs a weekly recovery above $19.24 and Q3 delivery against August guidance. A weekly close below $16.00 breaks the price case, while September’s Optiq rollout has yet to establish… Special situation · AI enterprise software catalyst ·

All 92 AI enterprise software dossiers →

Cyclical industrials

70 dossiers

Worked today · maturing.

RXO RXO, Inc. fresh MEDIUM Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to… Compounder · Freight & logistics · Cyclical industrials analysed · ARCB ArcBest Corporation fresh LOW ArcBest’s cost-reduction rebound failed its published price condition at the 2026-09-18 weekly close of $128.73. Third-quarter results still test recurring savings and preservation of the second-quarter 90.8% adjusted Asset-Based operating… Special situation · Freight & logistics · Cyclical industrials catalyst · JBHT J.B. Hunt Transport Services, Inc. fresh LOW J.B. Hunt’s freight-recovery thesis was invalidated by the 2026-09-18 weekly close below $265. The estimated 2026-10-15 report tests whether intermodal pricing and profit growth can support a separate recovery case after September’s cost… Compounder · Freight & logistics · Cyclical industrials catalyst · XPO XPO, Inc. fresh LOW XPO, Inc.'s shipment-and-margin thesis failed its price test when the 2026-09-18 weekly close of $174.25 breached $185. The 2026-10-29 results still test shipment growth and management's guidance for an adjusted less-than-truckload… Compounder · Freight & logistics · Cyclical industrials catalyst · BWMN Bowman Consulting Group Ltd. HIGH Bowman Consulting Group’s $43.00 cash acquisition makes merger completion the central thesis. The case resolves with payment of the announced consideration before a daily close below $40.50; the 2026-09-13 go-shop deadline narrows… Earnings inflection · Cyclical industrials catalyst · AGCO AGCO Corporation MEDIUM AGCO Corporation's valuation reflects a 2027 farm-equipment recovery that remains unconfirmed by reported demand. A weekly close above the $139.71 market high recorded as of 2026-09-04 and Q3 results meeting July guidance would confirm the… Compounder · Cyclical industrials catalyst · CLF Cleveland-Cliffs Inc. fresh MEDIUM Cleveland-Cliffs’ tariff-supported cash-flow recovery needs another positive quarter and a weekly close above $12.50. A weekly close below $11.62 would invalidate the recovery, while unresolved labor terms remain the nearest operating… Special situation · Cyclical industrials · Industrial power & grid catalyst · CNH CNH INDUSTRIAL N.V. MEDIUM CNH Industrial's farm-equipment recovery is being priced ahead of earnings after September's analyst upgrades. The next quarterly report tests margin recovery, while a weekly close below $12.50 invalidates the re-rating leg. Compounder · Cyclical industrials catalyst · HNI HNI Corporation fresh MEDIUM HNI Corporation’s Steelcase integration could sustain earnings growth despite weak organic sales, but the September 18 close broke the prior shelf. The next quarterly report tests delivery against July’s raised outlook; a weekly close… Special situation · Cyclical industrials · Housing, homebuilders & proptech catalyst ·

All 70 Cyclical industrials dossiers →

Consumer discretionary rotation

69 dossiers

Worked today · maturing.

CRSR Corsair Gaming, Inc. MEDIUM Corsair Gaming's margin-recovery story is approaching its $14.35 annual high; a weekly close above that level would confirm the recovery leg. A weekly close below the market's $10.93 August anchor would invalidate it, while the next… Special situation · Prediction markets & betting · Consumer discretionary rotation catalyst · HNST The Honest Company, Inc. MEDIUM The Honest Company’s margin re-rating depends on Q3 confirming organic growth and profitability excluding tariff refunds. Confirmation requires organic growth of at least 5%, underlying adjusted gross margin of at least 43.8% and unchanged… Special situation · Consumer discretionary rotation catalyst · IBTA Ibotta, Inc. fresh MEDIUM Ibotta's rally prices a repeatable recovery in digital-promotions revenue; Q3 revenue above $86 million with year-over-year growth would confirm the next leg, unless a weekly close below $33 invalidates it first. Defensive · Crypto exchanges & financials · Consumer discretionary rotation analysed · ANF Abercrombie & Fitch Co. fresh LOW Abercrombie & Fitch’s margin re-rating lacks price confirmation after the 2026-09-18 close of $135.76. Continuation requires a weekly close above $152.08 before Q3 results, estimated for 2026-11-24, without first closing below $130. Special situation · Consumer discretionary rotation analysed · HBB Hamilton Beach Brands Holding Company fresh LOW Hamilton Beach Brands' tariff-refund re-rating needs durable underlying margins and renewed price strength. A weekly close above the September 11 reference high of $33.86 before a weekly close below $28.00 completes the price case;… Defensive · Consumer discretionary rotation analysed · ODD ODDITY Tech Ltd. fresh LOW Broken compounder with exactly one dated event: the 2026-09-09 pre-market Q2 print. Price ran $13.22 (2026-08-21) to $14.35 (2026-08-28) on no company disclosure since 2026-07-22, leaving it ~30% above the $11.07 consensus target of 10… Earnings inflection · Consumer discretionary rotation analysed · SG Sweetgreen, Inc. fresh LOW Sweetgreen’s recovery thesis links sales stabilization to KeyBanc’s 2026-09-08 target of $9. The next quarterly results test the operating case; a daily close at or above $9 completes the price case, while a weekly close below $6.00… Retail squeeze · Consumer discretionary rotation catalyst · W Wayfair Inc. fresh LOW Margin-inflection turnaround has stalled: after the June Evercore-driven pop, W has faded ~10% back to the ~$84–85 recovery base ahead of the binary Aug 4 Q2 print. Wedbush's Jul 16 Neutral/$104 initiation and a ~$100-capped consensus mark… Special situation · Consumer discretionary rotation analysed · WPP WPP PLC fresh LOW WPP’s re-rating rests on revenue stabilisation after the September index-promotion case expired. The next quarterly update must improve on the 2.8% like-for-like decline and retain 12–13% margin guidance before a weekly close below $24… Special situation · Consumer discretionary rotation · AI enterprise software analysed ·

All 69 Consumer discretionary rotation dossiers →

Binary-catalyst biotech

68 dossiers

Worked today · saturated.

ABSI Absci Corporation fresh MEDIUM Absci Corporation’s valuation rests on ABS-201 delivering human hair-growth efficacy in the guided second half of 2026. Separation from placebo would validate the case; a weekly close below $7.50, absent efficacy or a missed readout window… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics analysed · ALVO Alvotech MEDIUM Alvotech's recovery prices in Q4 2026 FDA approvals after the Reykjavik inspection closure announced on 2026-07-29. AVT05 and AVT06 approvals within that window would confirm the regulatory-repair case; another manufacturing-related… Earnings inflection · Binary-catalyst biotech catalyst · FRNM Freenome, Inc. MEDIUM Freenome's approved blood-test story depends on Abbott launching SimpleScreen CRC and demonstrating reimbursed testing. Carelon's 2026-11-15 guideline strengthens the pathway; a weekly close below $14 or no US launch by 2026-12-31… Earnings inflection · Binary-catalyst biotech analysed · GHRS GH Research PLC MEDIUM Eli Lilly's up-to-$3.8B AtaiBeckley buy (2026-07-16) put a large-cap price on 5-MeO-DMT for depression; GHRS is now the last independent pure-play, with best-in-class inhaled GH001 Phase 2b data, that the sector is repricing as the next… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics catalyst · MANE Veradermics, Incorporated MEDIUM Veradermics’ oral minoxidil story depends on Study ‘304’ replicating the reported hair-growth benefit by year-end 2026. Failed replication, a weekly close below $85, or the reporting window expiring without results would invalidate the… Earnings inflection · Precision biotech & therapeutics · Binary-catalyst biotech analysed · ORKA Oruka Therapeutics, Inc. MEDIUM Supply overhang cleared: the 2026-07-01 Fairmount $300M block at $84.43 was absorbed and price closed $92.70 on 07-17 (+11.6%), 5% off the 52-week high, with 19.85% short interest still rising. Long-acting I&I re-rated by the $10.9B… Earnings inflection · Binary-catalyst biotech · Oncology & immunology catalyst · TARS Tarsus Pharmaceuticals, Inc. MEDIUM Tarsus Pharmaceuticals’ eye-care expansion depends on XDEMVY sustaining growth after the Alkeus acquisition. The case requires next-quarter sales above Q2 2026’s $173.9 million and retention or an increase of both boundaries of the… Compounder · Binary-catalyst biotech catalyst · CLYM Climb Bio, Inc. fresh LOW Climb Bio's re-rating depends on Q4 2026 budoprutug patient data establishing clinical benefit. Recovery of the $17.84 adjusted annual high would confirm the price leg; a weekly close below $13.30 or a delay beyond the guided clinical… Earnings inflection · Precision biotech & therapeutics · Oncology & immunology analysed · IMRN Immuron Limited LOW Immuron’s consumer-health expansion needs a dated US PROIBS launch and disclosed commercial terms to validate its September repricing. The 2026-09-04 agreement supplies neither; a weekly close below $1.65 or an annual report without those… Retail squeeze · Binary-catalyst biotech catalyst ·

All 68 Binary-catalyst biotech dossiers →

Medtech & diagnostics

63 dossiers

Worked today · maturing.

TXG 10x Genomics, Inc. fresh MEDIUM 10x Genomics' Atera recovery now needs deliveries and revenue confirmation after clearing its earlier price hurdle. Approximately 40 second-half 2026 shipments and full-year revenue of $610–630 million would substantiate the case before a… Special situation · Medtech & diagnostics catalyst · ITGR Integer Holdings Corporation HIGH Integer Holdings Corporation’s $127.00 cash acquisition by KKR remains a completion thesis, strengthened by the 2026-09-03 merger proxy. Completion by year-end 2026 would settle the case; a daily close below $118 invalidates it. Earnings inflection · M&A & special situations · Medtech & diagnostics catalyst · PSNL Personalis, Inc. fresh HIGH The MRD story has been overtaken by a live sale process: StreetInsider reported 2026-07-17 that Personalis retained Centerview, TD Securities and Cooley after takeover interest from Merck (already a >10% holder and 19% of Q1 revenue) plus… Earnings inflection · Medtech & diagnostics · Oncology & immunology catalyst · VREX Varex Imaging Corporation HIGH Varex Imaging Corporation’s $18.90 cash acquisition by Teledyne remains a completion thesis. The 2026-09-08 preliminary proxy advances the process; payment resolves the case, while a daily close below $17.50 invalidates it. Earnings inflection · Medtech & diagnostics catalyst · ADPT Adaptive Biotechnologies Corporation MEDIUM clonoSEQ MRD pure-play inflecting to self-funding growth (MRD rev +53% YoY, profitability turning); June 15 Immune Medicine separation adds a value-unlock leg. But the tape just broke to fresh 52-wk highs (~$22.92) above the $20–22… Defensive · Medtech & diagnostics catalyst · ATRC AtriCure, Inc. fresh MEDIUM AtriCure’s profitability and clinical-expansion story now has to sustain its re-rating after September 21 index inclusion. A weekly close at or above Needham’s $64 target would complete the price case; a weekly close below $47 would… Compounder · Medtech & diagnostics catalyst · BBNX Beta Bionics, Inc. fresh MEDIUM Beta Bionics’ new case is Mint commercialization after the September revenue cut broke the iLet growth thesis. Full U.S. launch within management’s Q1 2027 window would confirm the case; a weekly close below $17.25 would invalidate it. Earnings inflection · Medtech & diagnostics catalyst · CDNA CareDx, Inc. MEDIUM CareDx’s reimbursement repricing depends on its next quarterly report sustaining the $490–500 million revenue outlook issued on 2026-07-30. Canaccord’s 2026-09-02 initiation renewed attention, but a weekly close below $44 would invalidate… Earnings inflection · Medtech & diagnostics analysed · HAE Haemonetics Corporation fresh MEDIUM Haemonetics’ CSL agreement supports a plasma-recovery thesis, but November must supply a quantified revenue contribution and transition timetable. Citi’s September 17 upgrade strengthens analyst support; a weekly close below $91… Special situation · Medtech & diagnostics catalyst ·

All 63 Medtech & diagnostics dossiers →

Oncology & immunology

63 dossiers

Last produced 9 September 2026 — 11 days ago, maturing then.

PSNL Personalis, Inc. fresh HIGH The MRD story has been overtaken by a live sale process: StreetInsider reported 2026-07-17 that Personalis retained Centerview, TD Securities and Cooley after takeover interest from Merck (already a >10% holder and 19% of Q1 revenue) plus… Earnings inflection · Medtech & diagnostics · Oncology & immunology catalyst · RVMD Revolution Medicines, Inc. fresh HIGH Regulatory-clock narrative re-accelerating: the rolling NDA under the FDA National Priority Voucher is "nearing completion" (2026-07-07) and the EMA opened a phased CHMP review the same day, while the Street ceiling walked from ~$186 to… Compounder · Precision biotech & therapeutics · Oncology & immunology catalyst · DCTH Delcath Systems, Inc. fresh MEDIUM Delcath Systems’ self-funded liver-treatment expansion must sustain its raised revenue outlook. Confirmation requires maintained $104–108 million guidance at the next quarterly report and a weekly close above $17.36 before a weekly close… Defensive · Oncology & immunology analysed · IOVA Iovance Biotherapeutics, Inc. fresh MEDIUM Iovance Biotherapeutics' Amtagvi ramp supports a higher 2026 revenue outlook; a company-issued range above $350–370 million by 2026-09-30 would confirm it. An unchanged range or a missed update deadline would invalidate the revision thesis. Compounder · Oncology & immunology analysed · NVCT Nuvectis Pharma, Inc. MEDIUM Nuvectis Pharma’s expanded-pipeline valuation depends on US development of its Haisco compounds. The case requires announced IND submissions for both assets and a weekly close above the $28.53 trailing high by 2026-12-31, before a weekly… Defensive · Oncology & immunology · Precision biotech & therapeutics catalyst · ORKA Oruka Therapeutics, Inc. MEDIUM Supply overhang cleared: the 2026-07-01 Fairmount $300M block at $84.43 was absorbed and price closed $92.70 on 07-17 (+11.6%), 5% off the 52-week high, with 19.85% short interest still rising. Long-acting I&I re-rated by the $10.9B… Earnings inflection · Binary-catalyst biotech · Oncology & immunology catalyst · SMMT Summit Therapeutics Inc. fresh MEDIUM Summit Therapeutics’ ivonescimab thesis is that quantified survival evidence converts into US approval by 2026-11-14 before a weekly close below $15.00. September’s disclosures strengthen the clinical case, but the global trial’s primary… Earnings inflection · Oncology & immunology analysed · VSTM Verastem, Inc. MEDIUM Verastem’s commercial launch supports a VS-7375 clinical revaluation thesis, tested by the newly scheduled 2026-10-14 efficacy update. The case requires reported tumor responses and a daily close above the 2026-09-02 reference close of… Earnings inflection · Oncology & immunology catalyst · ZLAB Zai Lab Limited MEDIUM Zai Lab's global drug-development re-rating depends on October's zoci data leading to first-line lung-cancer Phase 3 initiation by 2026-12-31. The case requires those milestones before a weekly close below $22; the partnered ALKIVIA… Earnings inflection · Oncology & immunology analysed ·

All 63 Oncology & immunology dossiers →

Managed care & health services

57 dossiers

Worked today · saturated.

OSCR Oscar Health, Inc. fresh MEDIUM Oscar Health's higher earnings outlook and quantified 2027 pricing support a post-Investor-Day rerating. A weekly close above $32.76 before a weekly close below $29.83 would complete the price-confirmation test; the September 18, 2026… Earnings inflection · Managed care & health services analysed · CNC Centene Corporation fresh LOW Centene's margin-repair case requires sustained earnings guidance and a weekly close above $68.72 by its 2026-10-27 results. September's reaffirmation supports the earnings leg, but a weekly close below $65 or withdrawal or reduction of… Earnings inflection · Managed care & health services analysed · HNGE Hinge Health, Inc. fresh LOW Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating… Compounder · Managed care & health services analysed · HUM Humana Inc. fresh LOW Humana's Medicare Advantage margin-recovery story faces a renewed price test: an adjusted daily close above $409.80 before a daily close below $383. The September 1, 2026 earnings reaffirmation supports stability, while October Star… Compounder · Managed care & health services catalyst · ASTH Astrana Health Inc. MEDIUM Astrana Health’s full-risk care story depends on meeting Q3 revenue and profit guidance while preserving its raised annual profit outlook. That operational result must arrive before a weekly close below $34 invalidates the recovery thesis. Defensive · Managed care & health services analysed · AVAH Aveanna Healthcare Holdings Inc. fresh MEDIUM Aveanna Healthcare’s earnings recovery supports further revaluation if its next report raises annual adjusted EBITDA guidance above the greater-than-$365 million outlook set on 2026-08-13. A weekly close below $11.75 or an unchanged or… Special situation · Managed care & health services analysed · FIGS FIGS, Inc. MEDIUM The post-print shelf resolved upward: the 2026-08-28 close of $15.42 sits 8.1% above the 2026-08-07 mark of $14.26 and 9.9% under the $17.12 52-week high, with no company-dated news since the 2026-08-07 target revisions. The re-rating off… Defensive · Managed care & health services catalyst · GEO The GEO Group, Inc. MEDIUM The GEO Group’s detention-contract story depends on year-end 2026 activation, with normalized earnings expected in early 2027. A weekly close above $32.77 would confirm the price leg; a weekly close below $28 or a disclosed activation… Compounder · Travel & leisure · Managed care & health services catalyst · LFST LifeStance Health Group, Inc. fresh MEDIUM LifeStance Health's margin recovery faces a repeatability test after September's shareholder offering: Q3 must meet August guidance and the annual outlook must hold. A weekly close below $11.00 invalidates the market thesis. Special situation · Managed care & health services catalyst ·

All 57 Managed care & health services dossiers →

Oil, energy & geopolitical

44 dossiers

Worked today · maturing.

BWLP BW LPG Limited fresh MEDIUM BW LPG Limited’s contracted freight earnings support dividend continuation; its 2026-11-24 report must show Q3 realised shipping TCE above Q2’s $74,000 per day and a dividend of at least $0.95 per share. A weekly close below $22.00… Compounder · Freight & logistics · Oil, energy & geopolitical analysed · CMBT CMB.TECH NV fresh MEDIUM CMB.TECH's vessel-disposal and cash-return story supports further upside if the proposed October distribution is delivered. The case requires payment of $0.64 per share and a weekly close above $20.41 by 2026-10-31, before a weekly close… Special situation · Oil, energy & geopolitical · Freight & logistics catalyst · CVI CVR ENERGY, INC. MEDIUM CVR Energy’s refining thesis is that Hormuz disruption lifts reported margins above second-quarter 2026’s $9.94 per throughput barrel. Third-quarter results test that inference; a weekly close below $39 invalidates the price structure. Compounder · Oil, energy & geopolitical catalyst · DINO HF Sinclair Corporation MEDIUM HF Sinclair’s refining-margin and separation story now has fresh UBS support. The case requires the next quarterly report to sustain second-quarter adjusted refinery gross margin of $25.95 per produced barrel sold on comparable throughput,… Compounder · Oil, energy & geopolitical catalyst · DK Delek US Holdings, Inc. MEDIUM Delek US's refining recovery supports the August breakout, but September's distillate build weakens the scarcity leg. Q3 throughput and expense delivery must confirm the earnings case before a weekly close below $64 invalidates the… Compounder · Oil, energy & geopolitical catalyst · FTK Flotek Industries, Inc. fresh MEDIUM Legacy oilfield chemistry re-rating into a power/measurement business: Data Analytics hit 51% of gross profit in Q2 2026, the 2026-08-03 PREPA award adds ~$400M of 10-year expected backlog, and the 2026-08-04 guide went to $340–350M from… Special situation · Oil, energy & geopolitical catalyst · HP Helmerich & Payne, Inc. MEDIUM Helmerich & Payne’s crude-led drilling recovery needs fourth-quarter rig activity and margins to meet guidance and adjusted earnings to turn positive. Those results would confirm the operating case; a weekly close below $40 invalidates the… Cyclical recovery · Oil, energy & geopolitical catalyst · PBF PBF ENERGY INC. MEDIUM PBF Energy’s new high prices in sustained refining profits; Q3 adjusted earnings of at least $6.22 per share would confirm the case unless a weekly close below $75.48 first breaks the breakout. Compounder · Oil, energy & geopolitical catalyst · PSX Phillips 66 MEDIUM Phillips 66’s repricing depends on exceptional refining margins persisting into Q3 2026. The case plays out if Q3 realized refining margin reaches at least Q2’s $24.08 per barrel before a weekly close below $239 invalidates it. Compounder · Oil, energy & geopolitical catalyst ·

All 44 Oil, energy & geopolitical dossiers →

Freight & logistics

43 dossiers

Worked today · maturing.

RXO RXO, Inc. fresh MEDIUM Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to… Compounder · Freight & logistics · Cyclical industrials analysed · ARCB ArcBest Corporation fresh LOW ArcBest’s cost-reduction rebound failed its published price condition at the 2026-09-18 weekly close of $128.73. Third-quarter results still test recurring savings and preservation of the second-quarter 90.8% adjusted Asset-Based operating… Special situation · Freight & logistics · Cyclical industrials catalyst · JBHT J.B. Hunt Transport Services, Inc. fresh LOW J.B. Hunt’s freight-recovery thesis was invalidated by the 2026-09-18 weekly close below $265. The estimated 2026-10-15 report tests whether intermodal pricing and profit growth can support a separate recovery case after September’s cost… Compounder · Freight & logistics · Cyclical industrials catalyst · LSTR Landstar System, Inc. fresh LOW Landstar System's truckload repricing must produce further earnings improvement. The 2026-10-27 results settle the case if truck revenue per load grows year over year and earnings per share exceed the second quarter's $1.44 before a weekly… Defensive · Freight & logistics catalyst · XPO XPO, Inc. fresh LOW XPO, Inc.'s shipment-and-margin thesis failed its price test when the 2026-09-18 weekly close of $174.25 breached $185. The 2026-10-29 results still test shipment growth and management's guidance for an adjusted less-than-truckload… Compounder · Freight & logistics · Cyclical industrials catalyst · LPG Dorian Lpg Ltd HIGH Dorian LPG’s contracted freight surge supports September-quarter TCE above June’s record $75,926 per available day. Reported results settle the case; a weekly close below $47 invalidates the equity thesis first. Compounder · Freight & logistics catalyst · BWLP BW LPG Limited fresh MEDIUM BW LPG Limited’s contracted freight earnings support dividend continuation; its 2026-11-24 report must show Q3 realised shipping TCE above Q2’s $74,000 per day and a dividend of at least $0.95 per share. A weekly close below $22.00… Compounder · Freight & logistics · Oil, energy & geopolitical analysed · CMBT CMB.TECH NV fresh MEDIUM CMB.TECH's vessel-disposal and cash-return story supports further upside if the proposed October distribution is delivered. The case requires payment of $0.64 per share and a weekly close above $20.41 by 2026-10-31, before a weekly close… Special situation · Oil, energy & geopolitical · Freight & logistics catalyst · CYRX CryoPort, Inc. MEDIUM Q2 (2026-08-06) split the read: revenue $49.0M beat $48.21M and FY26 guide affirmed at $192–196M with adjusted EBITDA crossing to +$0.4M, but commercial CGT growth halved to +9% YoY from +26%. The narrative leg is now the profitability… Cyclical recovery · Rare disease & gene therapy · Precision biotech & therapeutics catalyst ·

All 43 Freight & logistics dossiers →

AI chips & memory

40 dossiers

Worked today · saturated.

AMD Advanced Micro Devices, Inc. fresh MEDIUM Advanced Micro Devices’ Helios story depends on OpenAI bringing the platform online in the fourth quarter of 2026. Confirmed operation would settle the deployment case; a weekly close below $456 or activation postponed beyond that quarter… Cyclical recovery · AI chips & memory analysed · MU Micron Technology, Inc. fresh MEDIUM Micron Technology's contracted memory revenue supports an earnings-durability thesis tested on 2026-09-30 against June's $50.0 billion ±$1.0 billion revenue guidance and an 86% adjusted gross-margin benchmark. A weekly close below $958… Cyclical recovery · AI chips & memory catalyst · SIMO Silicon Motion Technology Corporation fresh MEDIUM Silicon Motion's enterprise-storage expansion needs third-quarter 2026 revenue of at least $519 million to validate the recovery before a weekly close below $230 breaks it. September 15 supply and customer-ramp commentary supports the… Cyclical recovery · AI chips & memory catalyst · SNDK Sandisk Corporation fresh MEDIUM Sandisk’s contracted-revenue story has regained its post-Investor Day price level, leaving fiscal Q1 2027 delivery as the unresolved test. Revenue of at least $10.3 billion and non-GAAP gross margin of at least 83% would complete the case… Cyclical recovery · AI chips & memory catalyst · MRVL Marvell Technology, Inc. fresh LOW Custom-silicon ASIC royalty story intact, but the AI-semi theme is mid-correction — chips posted their worst month vs software on record (7/17) with money rotating into energy. Buying a falling sector with no confirmed higher low is the… Cyclical recovery · AI chips & memory catalyst · STX Seagate Technology Holdings PLC fresh LOW Maturing AI-storage supercycle with sell-side still chasing: Wells Fargo upgrade to Overweight $1,100 (7/10) and Citi Street-high $1,240 (7/13). But the DRAM ETF is down ~30% and Seagate's Q4 FY26 print ~2026-07-22 is a binary about two… Cyclical recovery · AI chips & memory catalyst · WDC Western Digital Corporation fresh LOW The 29% bounce off the 2026-07-28 low stalled: WDC closed $527.22 on 2026-08-03, −3.23% on a day its sector rose 0.58%, back under a rising 50-day at $562.65. Consensus (~$3.69B / $3.31–$3.35) still sits above the company's own $3.65B… Cyclical recovery · AI chips & memory analysed · BB BlackBerry Limited fresh LOW Q1 FY27 gave the pivot real numbers (QNX $72.3M vs the $60-64M guide, FY27 raised to $594-621M), but the parabola broke: after a $13.59 high the stock fell ~37% to ~$8.54 on a meme unwind plus insider selling. Narrative maturing, price… Retail squeeze · AI enterprise software · AI chips & memory catalyst · ARM Arm Holdings plc fresh LOW Data-center royalty doubled YoY for a second quarter, but Q2 FY27 royalty growth is guided to ~13% against 22% delivered. No Arm-specific disclosure has landed since 2026-07-29, so the bid is set by third parties — BofA's 2026-08-13… Cyclical recovery · AI chips & memory catalyst ·

All 40 AI chips & memory dossiers →

Critical materials & rare earths

36 dossiers

Last produced 6 September 2026 — 14 days ago, maturing then.

EGO Eldorado Gold Corporation MEDIUM Eldorado Gold’s Skouries expansion thesis now hinges on fourth-quarter 2026 commercial production after first concentrate on September 8. Delivery before a weekly close below $40 would validate the case; a delay into 2027 would contradict… Compounder · Critical materials & rare earths catalyst · FSM Fortuna Mining Corp. MEDIUM Fortuna Mining’s gold-supported cash generation funds its mine-growth story, but the September 11 retreat weakens the recovery case. A weekly close above $13.66 before a weekly close below $11.00 would confirm the equity thesis. Compounder · Critical materials & rare earths catalyst · IAG IAMGold Corporation MEDIUM IAMGOLD’s margin-expansion case depends on Côté lowering costs as gold support weakens. Q3 all-in sustaining costs within the published $2,000–$2,150 per-ounce range and retained annual production guidance would confirm the case before a… Compounder · Critical materials & rare earths catalyst · SSRM SSR Mining Inc. MEDIUM SSR Mining’s post-divestiture re-rating rests on cash and repurchases, with weaker momentum after the 2026-09-04 jobs report. A weekly close above the $39.21 market high would confirm the case before a weekly close below $33 invalidates it. Compounder · Critical materials & rare earths catalyst · CDE Coeur Mining, Inc. fresh LOW Coeur Mining’s cash-backed repair thesis requires price recovery and confirmation that reduced production guidance holds. A weekly close above the September $21.24 reference and reaffirmed guidance at the next quarterly report would… Compounder · Critical materials & rare earths catalyst · MP MP Materials Corp. fresh LOW MP Materials' domestic-magnet recovery failed its $50 weekly-close test on 2026-09-18; Q4 2026 General Motors shipments remain the unresolved operating test. Compounder · Critical materials & rare earths catalyst · ELE Elemental Royalty Corporation HIGH Elemental Royalty Corporation’s royalty-growth case turns on completing Vizsla by 2026-09-30 with GEO guidance intact. The 2026-09-08 Mexican clearance advances that case; a weekly close below $19.00 or a missed closing window invalidates… Cyclical recovery · Critical materials & rare earths catalyst · ALM Almonty Industries Inc. fresh MEDIUM Non-China tungsten narrative now trades on one venue: the TSX exit took effect 2026-07-31 and the ASX removal 2026-09-01, leaving Nasdaq and Frankfurt. The operating case is unchanged — Sangdong throughput since 2026-07-01, Q2 revenue… Compounder · Critical materials & rare earths · Defense & aerospace analysed · ARIS Aris Mining Corporation MEDIUM Aris Mining’s expansion case depends on Marmato producing first gold in Q4 2026 with annual production guidance intact. Company confirmation before a weekly close below $17.50 would establish the near-term commissioning leg; first gold… Compounder · Critical materials & rare earths catalyst ·

All 36 Critical materials & rare earths dossiers →

Semi foundry & equipment

35 dossiers

Worked today · saturated.

UMC United Microelectronic Corp. fresh LOW Silicon-photonics pivot re-rated the ADR ~3x, but the July blowoff to $28.96 round-tripped -26% to $21.25 in days while sell-side finally upgraded (Macquarie Outperform 2026-07-14) — late-stage distribution behaviour. The 2026-07-29 Q2… Special situation · Semi foundry & equipment catalyst · AEHR Aehr Test Systems MEDIUM Aehr Test Systems’ AI burn-in orders support a revenue-ramp thesis; the next results must preserve fiscal 2027 guidance of $130–150 million. The recovery case requires a weekly close above Lake Street’s $110 target before a weekly close… Cyclical recovery · Semi foundry & equipment analysed · TSEM Tower Semiconductor Ltd. MEDIUM Tower Semiconductor’s silicon-photonics expansion needs its next quarterly report to confirm the August revenue guide and July 2028 model. A weekly close below $195 would invalidate the price recovery before that operating confirmation. Cyclical recovery · Semi foundry & equipment catalyst · LRCX Lam Research Corporation fresh LOW The WFE/AI-memory capex trade that ran Lam +119% YTD into June has rolled into a group-wide correction — the worst month for chip stocks since 2008, memory momentum broken (Micron/SanDisk). The ~2026-07-29 FQ4 print is now the binary: it… Cyclical recovery · Semi foundry & equipment catalyst · ONTO Onto Innovation Inc. fresh LOW June breakout fully round-tripped: ATH $386.46 (6/30) to $279.85 (7/17), now below the 50-DMA at $294.49. The tell is non-participation — TSMC raised capex to $60-64B and ASML guided up twice on 7/15-16, and ONTO closed the week at its… Cyclical recovery · Semi foundry & equipment catalyst · TSM Taiwan Semiconductor Manufacturing Company Ltd. fresh LOW Q2 (7/16) beat every line and lifted FY26 growth guide above 40%, but the capex raise to $60–64B and a 2026-07-26 Samsung–Broadcom $200B foundry pact reopened the monopoly question. Theme cooled to maturing; price recovered to ~$415, still… Cyclical recovery · Semi foundry & equipment catalyst · ANDG Andersen Group Inc. fresh MEDIUM Post-IPO roll-up re-rate that survived its binary: Q2 revenue $217.7M beat $199.3M on 2026-08-12 and FY2026 was affirmed at $980M–$1.0B, with four target raises to $49–57 on 2026-08-13. The print is behind it and no dated catalyst sits… Defensive · Semi foundry & equipment catalyst · ATEYY Advantest Corporation fresh MEDIUM Advantest Corporation’s AI-testing thesis requires October 28 results to sustain July’s raised forecasts and a weekly close above $216.24 before a weekly close below $200. September 10 foundry growth supports demand indirectly; subsequent… Cyclical recovery · Semi foundry & equipment · AI chips & memory catalyst · COHU Cohu, Inc. MEDIUM Best fundamental print of the AI cycle (2026-07-30: rev $149M vs $144.08M cons.; Q3 guided $163–177M vs $146.33M) collided with a sector de-rate — the stock closed $52.88 on 2026-08-07, 28.5% under its $73.91 high and beneath the June… Cyclical recovery · AI datacenter infrastructure · Semi foundry & equipment analysed ·

All 35 Semi foundry & equipment dossiers →

Cybersecurity

31 dossiers

Last produced 8 September 2026 — 12 days ago, saturated then.

OKTA Okta, Inc. fresh MEDIUM Identity-security re-rating in its second, sell-side-led leg; the upgrade wave is still building nearly two months post-print — Wells Fargo lifted its target to $150 from $100 on 2026-07-20, collapsing the low-end dispersion. Cyber theme… Defensive · Cybersecurity catalyst · AAMI Acadian Asset Management Inc. MEDIUM Acadian Asset Management’s repricing depends on client inflows sustaining higher fees and margins. Positive third-quarter flows, management fees of at least $176.5 million and an economic net income operating margin of at least 40.3% would… Special situation · Cybersecurity analysed · CRWD CrowdStrike Holdings, Inc. fresh MEDIUM Fal.Con (2026-08-31 to 09-03) delivered real product — Falcon Guardian, Falcon IQ, GPT-5.6 Cyber in Falcon, Anthropic marketplace distribution — and nine broker actions through 2026-09-04 including Truist $300, yet CRWD closed $213.10 on… Compounder · Cybersecurity · AI enterprise software analysed · FROG JFrog Ltd. fresh MEDIUM Software-supply-chain-security plus AI-agent "trust layer" narrative keeps re-rating: the analyst cluster now leads price above $100 (UBS Buy $110 Jul 2, Truist Buy $105 Jul 9), confirming the continuation tell flagged in June.… Theme leader · Cybersecurity · AI enterprise software analysed · FTNT Fortinet, Inc. fresh MEDIUM Q2 (2026-07-29) resolved up — revenue $2.047B vs ~$1.89B, product +52% YoY, FY26 guide raised to $8.020–8.180B — but price has gone nowhere since: $161.95 on 07-31, $160.01 on 08-14, still 4.9% under the $168.29 high. The 44-analyst mean… Theme leader · Cybersecurity · AI datacenter infrastructure analysed · NET Cloudflare, Inc. MEDIUM Cloudflare’s AI security and agent-infrastructure story supports a recovery toward its recorded $330.83 high. The case plays out on a weekly close above that level by the listed 2026-10-29 results date and fails on a weekly close below… Cyclical recovery · AI enterprise software · AI datacenter infrastructure catalyst · PCTY Paylocity Holding Corporation MEDIUM Post-print re-rating leg: the 2026-08-04 Q4 FY26 beat ($1.84 adj. EPS vs $1.61 est.) triggered five price-target raises in 48 hours and a $150.42 close on 2026-08-07, +35.5% over three months. The buy is multiple recovery in mid-cap HCM… Theme leader · Cybersecurity catalyst · BB BlackBerry Limited fresh LOW Q1 FY27 gave the pivot real numbers (QNX $72.3M vs the $60-64M guide, FY27 raised to $594-621M), but the parabola broke: after a $13.59 high the stock fell ~37% to ~$8.54 on a meme unwind plus insider selling. Narrative maturing, price… Retail squeeze · AI enterprise software · AI chips & memory catalyst · ESTC Elastic N.V. LOW AI-retrieval-layer narrative accelerating: Q4 FY26 total RPO $1.98B grew 28% YoY against revenue +16%, and the 2026-07-30 OpenAI partnership re-rated the name 56.8% in three months. The 2026-08-27 Q1 FY27 print is the binary — company… Theme leader · Cybersecurity · AI enterprise software catalyst ·

All 31 Cybersecurity dossiers →

Crypto exchanges & financials

26 dossiers

Worked today · maturing.

ASST Strive, Inc. MEDIUM Strive, Inc.'s bitcoin-treasury premium thesis depends on increasing bitcoin per diluted common share. A company-reported year-to-date Bitcoin Yield above the 40.8% reading dated 2026-08-28 would confirm the case before a weekly close… Compounder · Crypto exchanges & financials analysed · BULL Webull Corporation MEDIUM June dormant-to-leader flip is confirming: the ~$7.52 breakout resolved up on the 2026-07-21 surge, Rosenblatt lifted its target to $13 (2026-07-16), and June ops printed 28.2M users / $800M net deposits. Theme accelerating; read is a… Retail squeeze · Crypto exchanges & financials catalyst · COIN Coinbase Global, Inc. fresh MEDIUM Coinbase’s recovery now rests on agency-led crypto market access after the Senate setback. Confirmation requires a weekly close above the historical $196.07 reference and third-quarter subscription-and-services revenue within the published… Compounder · Crypto exchanges & financials catalyst · HOOD Robinhood Markets, Inc. MEDIUM Robinhood Markets' September repricing now includes prediction-market infrastructure alongside on-chain finance. Stronger August activity and a weekly close above $124.72 would confirm continuation; a weekly close below $107 would… Compounder · Crypto exchanges & financials catalyst · IBTA Ibotta, Inc. fresh MEDIUM Ibotta's rally prices a repeatable recovery in digital-promotions revenue; Q3 revenue above $86 million with year-over-year growth would confirm the next leg, unless a weekly close below $33 invalidates it first. Defensive · Crypto exchanges & financials · Consumer discretionary rotation analysed · SBET SharpLink, Inc. MEDIUM SharpLink's Ether treasury discount is the recovery thesis: The Block reported a 0.84-times net asset value multiple on 2026-09-07. The case plays out if a comparable valuation reaches net asset value before a weekly close below $7.50… Special situation · Crypto exchanges & financials catalyst · BLSH Bullish LOW Bullish's regulatory repricing thesis requires successful CLARITY Act cloture followed by a weekly close above $37.10 before a weekly close below $31. The September 15, 2026 milestone is motion ripening, while the September 9 close of… Earnings inflection · Crypto exchanges & financials catalyst · BMNR BitMine Immersion Technologies, Inc. LOW Premium-to-NAV funding engine is closed; the 2026-08-10 release shows capital flipping from coin to float — 7,391 ETH bought for $14.3M (smallest week of 2026) against 3.0M shares retired, with cash down to $104M from $173M. The narrative… Compounder · Crypto exchanges & financials catalyst · BTCS BTCS Inc. LOW BTCS Inc.’s Ethereum recovery thesis requires stronger DeFi earnings without renewed borrowing. The next Q3 disclosure must show gross profit above Q2 2026’s $1.5 million and debt no higher than June’s $50.4 million before a weekly close… Compounder · Crypto exchanges & financials catalyst ·

All 26 Crypto exchanges & financials dossiers →

GPU cloud & neoclouds

17 dossiers

Worked today · saturated.

CRWV CoreWeave, Inc. fresh MEDIUM Post-print repricing is holding but fading: the 2026-08-12 gap to $107.73 is unfilled after closes of $106.29 and $105.26, RSI 71.1. Q2 printed $128M adjusted operating income against a $30–90M guide, and the $2.6B facility closed… Compounder · GPU cloud & neoclouds · AI datacenter infrastructure catalyst · IREN IREN Limited MEDIUM IREN Limited’s recovery rests on converting contracted AI cloud capacity into operating revenue by 2026-12-31. Management’s $4 billion operating-ARR target settles the conversion case, while a weekly close below $35 invalidates the… Special situation · GPU cloud & neoclouds catalyst · SPCX SpaceX (Space Exploration Technologies Corp.) MEDIUM SpaceX’s compute expansion now has a price breakout behind it; September capacity delivery and the December contract start test revenue conversion. A weekly close below $146.15 invalidates the breakout thesis. Compounder · Space economy · AI datacenter infrastructure catalyst · RUM Rumble Inc. fresh LOW The sell-the-news break is now confirmed: RUM lost the $6.46–$6.66 100/200-day shelf and closed $5.76 on 2026-07-17, -19% from the post-rebrand tape and within 25% of the $4.62 52-week low. Every moving average is overhead. The 2026-08-10… Special situation · GPU cloud & neoclouds · AI datacenter infrastructure catalyst · NBIS Nebius Group N.V. fresh MEDIUM GPU-neocloud narrative re-accelerated after NVIDIA disclosed a 9.3% stake (7/20) and PT raises followed (Northland $410, Baird initiates Outperform $250); Alphabet's 7/22 "demand outpaces capacity" answers the Meta-Compute bear case. The… Compounder · GPU cloud & neoclouds catalyst · RIOT Riot Platforms, Inc. fresh MEDIUM Riot Platforms’ AI-leasing thesis depends on permanent project financing and resolution of interim borrowing before maturity. Binding funding consistent with management’s 2026-08-10 plan would establish delivery financing; a weekly close… Special situation · GPU cloud & neoclouds analysed · WULF TeraWulf Inc. fresh MEDIUM TeraWulf’s AI-landlord conversion turns on CB-4 earning rent in September 2026 before a weekly close below $14.50. Wells Fargo’s September 17 coverage initiation adds attention, but rental commencement remains unverified as of September 20. Special situation · GPU cloud & neoclouds catalyst · HUT Hut 8 Corp. fresh LOW Bitcoin-miner-to-AI-datacenter-landlord re-rate is now financed fact ($4.25B IG notes 6/4, ~$16.8B contracted backlog), but the momentum leg rolled from ~$127 to ~$105 as peers WULF/IREN captured the marquee Anthropic tenant deals (7/6)… Special situation · GPU cloud & neoclouds analysed · BLZE Backblaze, Inc. fresh MEDIUM Neocloud storage pick-and-shovel: the five-year ~$335M CoreWeave B2 Neo deal (2026-06-23) re-rated BLZE from the high-$7s to a 52-week high near $18, and sell-side is still chasing (Citizens to $16, 2026-07-23). Narrative accelerating but… Cyclical recovery · GPU cloud & neoclouds · AI datacenter infrastructure catalyst ·

All 17 GPU cloud & neoclouds dossiers →

Analog semiconductors

17 dossiers

Worked today · maturing.

MXL MaxLinear, Inc. fresh LOW The AI-optical revenue leg still compounds — Q3 guided to $210–220M against Q2's $168.8M — while the price leg makes new lows: the 2026-09-04 close of $62.74 is 51.0% below the $128.03 high with RSI(14) at 25.1, after roughly $50M of… Cyclical recovery · Analog semiconductors analysed · QRVO Qorvo, Inc. fresh LOW Qorvo trades as a fixed-ratio merger spread: 0.960 SWKS plus $32.50 cash. Skyworks' $74.02 close on 2026-09-04 implies $103.56 against Qorvo's $102.84 — about 0.70% gross, the thinnest of this coverage, after the acquirer rallied 12.5% in… Earnings inflection · Analog semiconductors catalyst · SMTC Semtech Corporation fresh LOW The mix-purification leg has lost its price leg: the August bounce round-tripped from a $140.35 close on 2026-08-14 to $124.09 on 2026-08-21, under the 2026-07-17 flush close. The binary moved forward — Q2 FY27 prints 2026-08-25 after the… Cyclical recovery · Analog semiconductors catalyst · ADI Analog Devices, Inc. fresh MEDIUM Analog Devices’ AI and industrial growth story supports a recovery thesis, with fourth-quarter delivery as the operating test. Revenue at or above the $4.3 billion guidance midpoint and a daily close above the supplied $444.13 annual high… Theme leader · Analog semiconductors · AI datacenter infrastructure catalyst · HIMX Himax Technologies, Inc. MEDIUM Himax Technologies' AI-sensing re-rating requires a named, shipping smart-glasses product and Q3 revenue meeting its August 6 guidance before a weekly close below $13. The September 11 reclaim of the post-earnings reference close improves… Theme leader · Analog semiconductors · AI chips & memory catalyst · SWKS Skyworks Solutions, Inc. fresh MEDIUM Skyworks Solutions' Qorvo merger story supports further repricing, with a weekly close above the September 18 high of $91.32 defining success. A weekly close below $84.40 invalidates the price thesis; completion beyond calendar 2026 would… Earnings inflection · Analog semiconductors analysed · TXN Texas Instruments Incorporated MEDIUM Texas Instruments’ analog and data-center recovery needs Q3 revenue to meet its July guidance and a weekly close above $272. A weekly close below $250 or Q3 revenue below $5.65 billion would invalidate the case; the September 11 close of… Theme leader · Analog semiconductors · AI datacenter infrastructure catalyst · ALGM Allegro MicroSystems, Inc. fresh LOW The June AI data-center power-attach re-rate has flipped from being marked up to marked down: TD Cowen cut its target to $66 (2026-07-13) and Barclays downgraded to Equal-Weight at $48 (2026-07-20), the first target below the June range —… Cyclical recovery · Analog semiconductors · AI datacenter infrastructure analysed · APH Amphenol Corporation LOW AI-interconnect content leg unchanged since the 2026-07-29 print — orders $10.7B, book-to-bill 1.23:1, Q3 guided above consensus — but the bid has not come back: $157.74 on 2026-08-28 is flat on the week while RSI(14) slid from 43.4 to… Cyclical recovery · AI datacenter infrastructure · Analog semiconductors catalyst ·

All 17 Analog semiconductors dossiers →

Space economy

17 dossiers

Last produced 6 September 2026 — 14 days ago, saturated then.

IRDM Iridium Communications Inc fresh MEDIUM Iridium Communications’ merger-discount thesis now has completed financing behind it; acquisition completion before a weekly close below $43.50 settles the case. Rocket Lab’s 2026-09-15 funding announcement advances the transaction, while… Earnings inflection · Space economy catalyst · SPCX SpaceX (Space Exploration Technologies Corp.) MEDIUM SpaceX’s compute expansion now has a price breakout behind it; September capacity delivery and the December contract start test revenue conversion. A weekly close below $146.15 invalidates the breakout thesis. Compounder · Space economy · AI datacenter infrastructure catalyst · RKLB Rocket Lab Corporation fresh MEDIUM Rocket Lab's stabilisation case rests on operating growth absorbing acquisition dilution after its September 15 funding announcement. Iridium approval on 2026-09-24 followed by a weekly close above $64.26 confirms the narrow case only if a… Compounder · Space economy catalyst · ARXS Arxis, Inc. MEDIUM Arxis’ defense-and-space acquisition story needs another revenue-guidance increase at the next quarterly report to confirm acceleration. The case requires organic growth to hold at the 21% reported on 2026-07-29 and ends first if a weekly… Cyclical recovery · Space economy · Defense & aerospace catalyst · ASTS AST SpaceMobile, Inc. LOW AST SpaceMobile’s spectrum-access recovery requires a disclosed Grain agreement and a weekly close above $62.40 by 2026-11-05. A weekly close below $55.74 would invalidate the case first. Earnings inflection · Space economy analysed · BKSY BlackSky Technology Inc. fresh LOW Gen-3 subscription ramp landed in Q2 (2026-08-06): revenue $33.316M vs $30.68M est, +50% YoY, adjusted EBITDA $4.7M, FY26 guide affirmed at $130–150M. But EPS missed at $(0.54) vs $(0.36), cash is $36.9M against a $50–60M capex guide, and… Defensive · Space economy · Defense & aerospace catalyst · FLY Firefly Aerospace Inc. LOW Narrative and price have fully decoupled: FLY stacked a $144M CLPS award, a Moon BASE seat and a $13M Mars subcontract into a -47% drawdown, falling 9.6% on 7/16 on the awards headline itself. At $19.27 vs a $45 IPO price and 31% below the… Defensive · Space economy · Defense & aerospace catalyst · LUNR Intuitive Machines, Inc. LOW The June 30 NASA Moon BASE award ($148.3M Nova-C) bought exactly one green session before the stock broke: seven straight down days into 2026-07-13 for -24.5%, -36.5% on the month, $13.80 on 2026-07-18 versus a $38.55 May high. A live… Retail squeeze · Space economy catalyst · PL Planet Labs PBC LOW Planet Labs’ satellite-data growth supports a tentative recovery case after the September 3 earnings beat failed to preserve its July range. A weekly close above $19.16 before a weekly close below $16.45 would establish the defined… Earnings inflection · Space economy analysed ·

All 17 Space economy dossiers →

Bitcoin miners

6 dossiers

Worked today · maturing.

CLSK CleanSpark, Inc. fresh HIGH Spring's binary resolved bullish: CleanSpark signed a $6.6B, 20-year Georgia data-center lease (2026-07-14) with an unnamed "global technology company," converting the BTC-miner-to-AI-infrastructure pivot from speculation into contracted… Special situation · Bitcoin miners · AI datacenter infrastructure catalyst · HIVE HIVE Digital Technologies Ltd. fresh LOW BTC-miner→AI-compute re-rating has its first blue-chip proof — BUZZ HPC's $220M Bell/Cohere sovereign-AI GPU deal (~$70M ARR) on top of $35M contracted ARR — but the stock stalled ~$3.79 below its early-June highs as BTC bled ~45-50% off… Special situation · Bitcoin miners analysed · MARA MARA Holdings, Inc. fresh LOW AI/HPC power-buildout re-rate is the leg being bought — the 2026-07-09 HIF deal adds up to 2 GW in Texas, lifting potential capacity toward ~4.8 GW — but the golden-cross base fully round-tripped to ~$11.4 as analysts cut across the board… Special situation · Bitcoin miners catalyst · BTDR Bitdeer Technologies Group fresh LOW Spring miner-to-AI re-rate has fully unwound: BTDR lost the $15 shelf to $12.56 (2026-07-09) as AI-cloud ARR plateaued at ~$69M for a 2nd month. A signed-but-not-effective Tydal colocation lease (2026-06-29) and a $36M Nevada plant are the… Special situation · Bitcoin miners · AI datacenter infrastructure analysed · KEEL Keel Infrastructure Corp. fresh LOW Former Bitfarms miner→AI/HPC-datacenter pivot has rolled over: June's push to ~$6.14 into Citizens' $10 initiation retraced to a ~$4.975 ref by 07-06, losing the $5.00 convert shelf and drifting toward the $4.00–4.20 base. Still zero… Special situation · AI datacenter infrastructure · Bitcoin miners analysed · TMC TMC the metals company Inc. fresh LOW The deep-sea-mining reshoring leg is broken: TMC has cut through the $3.93 prior 52-week low to a fresh $3.57 low near $3.74, roughly -67% from the $11.35 high, with no bid and no near-term catalyst. The decisive NOAA license decision is… Earnings inflection · Bitcoin miners · Critical materials & rare earths catalyst ·

Mega-cap AI platforms

6 dossiers

Last produced 11 September 2026 — 9 days ago, saturated then.

META Meta Platforms, Inc. MEDIUM Meta Platforms’ AI monetisation story gained a consumer product with Muse’s 2026-09-08 launch. Disclosed external AI revenue or contract value by the 2026-10-28 results would validate the commercial leg; a weekly close below $545 would… Compounder · Mega-cap AI platforms catalyst · AAPL Apple Inc. LOW July's rotation-crown has slipped — Polymarket now gives Apple 20% odds of ending 2026 as the largest company (7/24) and semis are breaking out again (NVDA 7/23). The live narrative is the 'anti-CapEx AI trade' as Alphabet turns… Earnings inflection · Mega-cap AI platforms · Managed care & health services analysed · AMZN Amazon.com, Inc. LOW Amazon's cloud-growth recovery case depends on earnings validating its infrastructure spending and price reclaiming the August record. A weekly close above $284.02 completes the price case; a weekly close below $245 invalidates it, with… Compounder · Mega-cap AI platforms · AI datacenter infrastructure analysed · BIDU Baidu, Inc. ADS LOW The last dated event in a flow-mechanical leg lands 2026-09-07: southbound Stock Connect eligibility for the Hong Kong counters that turned dual-primary on 2026-09-01. The ADR closed $95.58 on 2026-09-03, -41.2% from the $162.52 high, with… Special situation · EV & autonomous mobility · Mega-cap AI platforms catalyst · GOOG Alphabet Inc. LOW Alphabet’s Cloud backlog-conversion story needs sustained growth and margins without another capital-spending increase. The next quarterly report tests that case against the July results; a weekly close below $328 invalidates the… Compounder · Mega-cap AI platforms analysed · MSFT Microsoft Corporation LOW AI-capex derating still in control and now colliding with a hostile print tape: Alphabet lost ~$294B on 2026-07-24 punished purely for AI spend, Tesla/Intel/Google all sold post-earnings, and MSFT reports Q4 FY26 on 2026-07-29 AMC below… Compounder · Mega-cap AI platforms · AI datacenter infrastructure analysed ·

Dormant · 19

The theme run rebuilds its clusters every trading day and did not produce these in the last 14 days. The dossiers stay — each is dated research with its own published kill line — but the theme is not current work.

M&A & special situations

78 dossiers

Last produced 23 August 2026 — 28 days ago, maturing then.

All 78 M&A & special situations dossiers →

Industrial power & grid

33 dossiers

Last produced 3 September 2026 — 17 days ago, saturated then.

All 33 Industrial power & grid dossiers →

Defense & aerospace

28 dossiers

Last produced 21 August 2026 — 30 days ago, maturing then.

All 28 Defense & aerospace dossiers →

Fintech & consumer credit

27 dossiers

Last produced 3 September 2026 — 17 days ago, maturing then.

All 27 Fintech & consumer credit dossiers →

Housing, homebuilders & proptech

23 dossiers

Last produced 31 August 2026 — 20 days ago, accelerating then.

All 23 Housing, homebuilders & proptech dossiers →

Rare disease & gene therapy

23 dossiers

Last produced 7 August 2026 — 44 days ago, maturing then.

All 23 Rare disease & gene therapy dossiers →

Networking & optical

19 dossiers

Last produced 4 September 2026 — 16 days ago, saturated then.

All 19 Networking & optical dossiers →

Travel & leisure

18 dossiers

Last produced 10 August 2026 — 41 days ago, accelerating then.

All 18 Travel & leisure dossiers →

Emerging markets

15 dossiers

Last produced 4 August 2026 — 47 days ago, accelerating then.

All 15 Emerging markets dossiers →

Physical AI & robotics

14 dossiers

Last produced 9 July 2026 — 73 days ago, accelerating then.

All 14 Physical AI & robotics dossiers →

Squeeze & momentum setups

13 dossiers

Last produced 28 August 2026 — 23 days ago, accelerating then.

All 13 Squeeze & momentum setups dossiers →

Biofuels & low-carbon fuels

11 dossiers

Never produced by the theme run — these names carry the tag from an earlier taxonomy.

All 11 Biofuels & low-carbon fuels dossiers →

EV & autonomous mobility

11 dossiers

Last produced 3 September 2026 — 17 days ago, accelerating then.

All 11 EV & autonomous mobility dossiers →

Nuclear & uranium

10 dossiers

Last produced 3 September 2026 — 17 days ago, saturated then.

All 10 Nuclear & uranium dossiers →

Solar & clean energy

7 dossiers

Last produced 26 May 2026 — 117 days ago, saturated then.

All 7 Solar & clean energy dossiers →

Prediction markets & betting

6 dossiers

Last produced 31 July 2026 — 51 days ago, accelerating then.

All 6 Prediction markets & betting dossiers →

Quantum computing

6 dossiers

Last produced 3 September 2026 — 17 days ago, saturated then.

All 6 Quantum computing dossiers →

Small-cap value rotation

5 dossiers

Last produced 16 August 2026 — 35 days ago, accelerating then.

All 5 Small-cap value rotation dossiers →

Cannabis reclassification

3 dossiers

Last produced 15 May 2026 — 128 days ago, accelerating then.

All 3 Cannabis reclassification dossiers →

Common questions

What stock market themes are moving right now?

The 21 themes FrontierPicks currently tracks are led by Precision biotech & therapeutics, AI datacenter infrastructure, AI enterprise software, Cyclical industrials. A theme here is a set of tickers the model has classified as trading on the same narrative, not a sector label — so it cuts across GICS sectors when the catalyst does.

How does FrontierPicks decide what counts as a theme?

Themes are derived from the dossier corpus: the model tags each name with the narratives driving it, and a tag becomes a theme on this page once enough covered names share it to behave as a basket. The theme run rebuilds its clusters every trading day from a fixed set of 40 named themes, and produces the subset the market is actually moving on — 21 of them in the latest run. The rest keep their dossiers and are listed as dormant, dated to the day they were last worked, rather than shown as current work.

What is the difference between a theme and a sector?

A sector is a fixed classification of what a company does; a theme is a live claim about why a group of names is moving together now. A single theme routinely spans several sectors, and a name can belong to more than one theme or to none.